A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00391755
Recruitment Status : Terminated (Failure to recruit necessary number of patients.)
First Posted : October 24, 2006
Last Update Posted : February 10, 2012
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Patricia Shipley, MD, Charlottesville Neuroscience